Delivery Order SPE2DB25D9348-SPE2DB25FNMSU
- Not listed
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $9,181.00 for Botox 200 Unit Vials. The contract was awarded on May 8, 2025, with an ultimate completion date of May 30, 2025, and carries firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract, valued at $4,625.70 with a firm fixed-price structure, is scheduled for completion by October 9, 2025, and was awarded on September 18, 2025. This delivery order does not utilize a set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200-unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,700.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. The award, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, utilizes firm fixed-price delivery order pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $64,685 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200-unit vials. The contract, awarded on September 10, 2025, utilizes firm fixed-price pricing with an ultimate completion date of October 1, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, effective August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $3,234.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, executed on September 3, 2025, with an ultimate completion date of September 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,229.60 contract is for the supply of BOTOX 100 unit vials to support the recurring medical needs of military health facilities. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to...
- The Defense Logistics Agency has awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion...
- SPE2DB25D9348Indefinite Delivery Contract
- SPE2DB25D9348-SPE2DB25FNMSUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract, awarded on May 2, 2025, with an ultimate completion date of May 23, 2025, carries firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in Defense Department procurement. The company's contract portfolio demonstrates consistent success in delivering specialized pharmaceutical products, including prescription medications, biologics, and medical consumables to military health facilities. This particular delivery order for Botox reflects the company's capability to supply specialty pharmaceutical products required by federal healthcare systems, supporting DLA's mission to provision medical materials across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 5/2/25 |